These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30503960)

  • 1. Microbial balance in the intestinal microbiota and its association with diabetes, obesity and allergic disease.
    Gholizadeh P; Mahallei M; Pormohammad A; Varshochi M; Ganbarov K; Zeinalzadeh E; Yousefi B; Bastami M; Tanomand A; Mahmood SS; Yousefi M; Asgharzadeh M; Kafil HS
    Microb Pathog; 2019 Feb; 127():48-55. PubMed ID: 30503960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gut microbiota: its development and relation to certain diseases].
    Sepová HK; Dudík B; Bilková A
    Ceska Slov Farm; 2018; 66(6):267-273. PubMed ID: 29623708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
    Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
    Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human gut microbiota and its interactive connections to diet.
    Milani C; Ferrario C; Turroni F; Duranti S; Mangifesta M; van Sinderen D; Ventura M
    J Hum Nutr Diet; 2016 Oct; 29(5):539-46. PubMed ID: 27161433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the microbiota and probiotics in obesity.
    Fontané L; Benaiges D; Goday A; Llauradó G; Pedro-Botet J
    Clin Investig Arterioscler; 2018; 30(6):271-279. PubMed ID: 29804899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for primary prevention of type 1 diabetes by restoring a disappearing microbe.
    Insel R; Knip M
    Pediatr Diabetes; 2018 Dec; 19(8):1400-1406. PubMed ID: 30136344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond gut microbiota: understanding obesity and type 2 diabetes.
    Lau E; Carvalho D; Pina-Vaz C; Barbosa JA; Freitas P
    Hormones (Athens); 2015; 14(3):358-69. PubMed ID: 26188221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of the intestinal microbiota in programming health and disease.
    Goulet O
    Nutr Rev; 2015 Aug; 73 Suppl 1():32-40. PubMed ID: 26175488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gut microbiota: Description, role and pathophysiologic implications].
    Landman C; Quévrain E
    Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microbiota and metabolic syndrome].
    Altuntaş Y; Batman A
    Turk Kardiyol Dern Ars; 2017 Apr; 45(3):286-296. PubMed ID: 28429701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of gut micorbiome in obesity and diabetes.
    Górowska-Kowolik K; Chobot A
    World J Pediatr; 2019 Aug; 15(4):332-340. PubMed ID: 31134588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora].
    Drapkina OM; Korneeva ON
    Ter Arkh; 2016; 88(9):135-142. PubMed ID: 28635818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, diabetes, and the gut microbiome: an updated review.
    Singer-Englar T; Barlow G; Mathur R
    Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):3-15. PubMed ID: 30791839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotic Ingestion, Obesity, and Metabolic-Related Disorders: Results from NHANES, 1999-2014.
    Lau E; Neves JS; Ferreira-Magalhães M; Carvalho D; Freitas P
    Nutrients; 2019 Jun; 11(7):. PubMed ID: 31261830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interindividual variability in gut microbiota and host response to dietary interventions.
    Healey GR; Murphy R; Brough L; Butts CA; Coad J
    Nutr Rev; 2017 Dec; 75(12):1059-1080. PubMed ID: 29190368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.